Health economic simulation modeling of an AI-enabled clinical decision support system for coronary revascularization - Top-Institutions - MDSpire

Health economic simulation modeling of an AI-enabled clinical decision support system for coronary revascularization

  • By

  • Tom Mullie

  • Arjun Puri

  • Emma Bogner

  • Bryan Har

  • Colm J. Murphy

  • Robert C. Welsh

  • Benjamin Tyrrell

  • Christopher L. F. Sun

  • Joon Lee

  • February 16, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Surgery
    • Health Economics
    • Artificial Intelligence

  • #2

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Cardiology
    • Health Economics
    • Biomedical Informatics
    • Artificial Intelligence

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Cardiology
    • Artificial Intelligence
    • Health Economics
    • Biomedical Data Science

  • #4

    University of Alberta
    University of Alberta

    Edmonton, AB

    Key Differentiators

    • Cardiology
    • Health Economics
    • Artificial Intelligence
    • Population Health

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Health Economics
    • Artificial Intelligence
    • Clinical Epidemiology

Original Source(s)

Health economic simulation modeling of an AI-enabled clinical decision support system for coronary revascularization

  • by Tom Mullie, Arjun Puri, Emma Bogner, Bryan Har, Colm J. Murphy, Robert C. Welsh, Benjamin Tyrrell, Christopher L. F. Sun, Joon Lee

  • February 16, 2026

Related Content

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

Risk factors of bleeding in patients with atrial fibrillation undergoing percutaneous coronary intervention: an analysis from the MANJUSRI study

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.